Completed
Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV
NCT00144157
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Boehringer Ingelheim Investigational Site Capetown, South Africa
- Boehringer Ingelheim Investigational Site Parow, South Africa
- Boehringer Ingelheim Investigational Site Soweto, South Africa